5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis

O. Martinez Saez, F. Brasó-Maristany, G. Griguolo,L. Pare Brunet,M.V. Dieci,J. Cortés,A. Llombart Cussac, G. Villacampa, M. Marín-Aguilera,M. Rey, G. Goberna,M. Munoz, A. Vivancos,P. Villagrasa Gonzalez, J. Parker,P.F. Conte, A. Prat, T. Pascual, V. Guarneri

ESMO Open(2023)

引用 0|浏览2
暂无评分
关键词
breast cancer,risk-score,anti-her
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要